{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T14:36:42Z","timestamp":1794753402212,"version":"4.9.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16POST31170002"],"award-info":[{"award-number":["16POST31170002"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["MH098891"],"award-info":[{"award-number":["MH098891"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["MH072567"],"award-info":[{"award-number":["MH072567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL126559"],"award-info":[{"award-number":["HL126559"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA039576"],"award-info":[{"award-number":["DA039576"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA044579"],"award-info":[{"award-number":["DA044579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA040537"],"award-info":[{"award-number":["DA040537"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI073961"],"award-info":[{"award-number":["P30AI073961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>HIV-associated cerebrovascular events remain highly prevalent even in the current era of antiretroviral therapy (ART). We hypothesize that low-level HIV replication and associated inflammation endure despite antiretroviral treatment and affect ischemic stroke severity and outcomes. Using the EcoHIV infection model and the middle cerebral artery occlusion as the ischemic stroke model in mice, we present in vivo analysis of the relationship between HIV and stroke outcome. EcoHIV infection increases infarct size and negatively impacts tissue and functional recovery. Ischemic stroke also results in an increase in EcoHIV presence in the affected regions, suggesting post-stroke reactivation that magnifies pro-inflammatory status. Importantly, ART with a high CNS penetration effectiveness (CPE) is more beneficial than low CPE treatment in limiting tissue injury and accelerating post-stroke recovery. These results provide potential insight for treatment of HIV-infected patients that are at risk of developing cerebrovascular disease, such as ischemic stroke.<\/jats:p>","DOI":"10.1038\/s41467-019-10046-x","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T10:02:54Z","timestamp":1556704974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Targeting the HIV-infected brain to improve ischemic stroke outcome"],"prefix":"10.1038","volume":"10","author":[{"given":"Luc","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fannie","family":"M\u00e9roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournebize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rachel","family":"Leda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-2119","authenticated-orcid":false,"given":"Michal","family":"Toborek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"10046_CR1","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1093\/infdis\/jiw648","volume":"215","author":"TJ Henrich","year":"2017","unstructured":"Henrich, T. J., Deeks, S. G. & Pillai, S. K. Measuring the size of the latent human immunodeficiency virus reservoir: the present and future of evaluating eradication strategies. J. Infect. Dis. 215, S134\u2013S141 (2017).","journal-title":"J. Infect. Dis."},{"key":"10046_CR2","doi-asserted-by":"crossref","unstructured":"Mzingwane, M. L. & Tiemessen, C. T. Mechanisms of HIV persistence in HIV reservoirs. Rev. Med. Virol. 27, 1924 (2017).","DOI":"10.1002\/rmv.1924"},{"key":"10046_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0323-4","volume":"13","author":"AJ Kandathil","year":"2016","unstructured":"Kandathil, A. J., Sugawara, S. & Balagopal, A. Are T cells the only HIV-1 reservoir? Retrovirology 13, 86 (2016).","journal-title":"Retrovirology"},{"key":"10046_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/COH.0000000000000293","volume":"11","author":"JK Wong","year":"2016","unstructured":"Wong, J. K. & Yukl, S. A. Tissue reservoirs of HIV. Curr. Opin. HIV AIDS 11, 362\u2013370 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10046_CR5","first-page":"376","volume":"11","author":"JB Sacha","year":"2016","unstructured":"Sacha, J. B. & Ndhlovu, L. C. Strategies to target non-T-cell HIV reservoirs. Curr Opin. HIV AIDS 11, 376\u2013382 (2016).","journal-title":"HIV AIDS"},{"key":"10046_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fimmu.2016.00397","volume":"7","author":"C Marban","year":"2016","unstructured":"Marban, C. et al. Targeting the brain reservoirs: toward an HIV cure. Front Immunol. 7, 397 (2016).","journal-title":"Front Immunol."},{"key":"10046_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/brain\/awy339","volume":"142","author":"L Bertrand","year":"2019","unstructured":"Bertrand, L., Cho, H. J. & Toborek, M. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain 142, 502\u2013511 (2019).","journal-title":"Brain"},{"key":"10046_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/COH.0000000000000287","volume":"11","author":"J Martinez-Picado","year":"2016","unstructured":"Martinez-Picado, J. & Deeks, S. G. Persistent HIV-1 replication during antiretroviral therapy. Curr. Opin. HIV AIDS 11, 417\u2013423 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10046_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort C.","year":"2008","unstructured":"Antiretroviral Therapy Cohort C. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372, 293\u2013299 (2008).","journal-title":"Lancet"},{"key":"10046_CR10","doi-asserted-by":"publisher","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","volume":"8","author":"H Samji","year":"2013","unstructured":"Samji, H. et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE 8, e81355 (2013).","journal-title":"PLoS ONE"},{"key":"10046_CR11","unstructured":"Aging USSSCo. In: Hearing: Older Americans (One Hundred Thirteenth Congress, Library of Congress, Washington, 2013)."},{"key":"10046_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","volume":"60","author":"FC Chow","year":"2012","unstructured":"Chow, F. C. et al. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J. Acquir Immune Defic. Syndr. 60, 351\u2013358 (2012).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10046_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0606-5","volume":"19","author":"S Farhadian","year":"2017","unstructured":"Farhadian, S., Patel, P. & Spudich, S. Neurological complications of HIV Infection. Curr. Infect. Dis. Rep. 19, 50 (2017).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10046_CR14","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","volume":"264","author":"C Eggers","year":"2017","unstructured":"Eggers, C. et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J. Neurol. 264, 1715\u20131727 (2017).","journal-title":"J. Neurol."},{"key":"10046_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11904-016-0330-z","volume":"13","author":"AL Willig","year":"2016","unstructured":"Willig, A. L. & Overton, E. T. Metabolic complications and glucose metabolism in HIV infection: a review of the evidence. Curr. HIV\/AIDS Rep. 13, 289\u2013296 (2016).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10046_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.idc.2014.05.003","volume":"28","author":"AH Warriner","year":"2014","unstructured":"Warriner, A. H., Burkholder, G. A. & Overton, E. T. HIV-related metabolic comorbidities in the current ART era. Infect. Dis. Clin. North Am. 28, 457\u2013476 (2014).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10046_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12012-015-9314-2","volume":"16","author":"M Weiss","year":"2016","unstructured":"Weiss, M. et al. Efavirenz causes oxidative stress, endoplasmic reticulum stress, and autophagy in endothelial cells. Cardiovasc Toxicol. 16, 90\u201399 (2016).","journal-title":"Cardiovasc Toxicol."},{"key":"10046_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12985-015-0298-0","volume":"12","author":"M Borsa","year":"2015","unstructured":"Borsa, M. et al. HIV infection and antiretroviral therapy lead to unfolded protein response activation. Virol. J. 12, 77 (2015).","journal-title":"Virol. J."},{"key":"10046_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QAI.0b013e31826afbfc","volume":"61","author":"D Gomez-Garre","year":"2012","unstructured":"Gomez-Garre, D. et al. Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis. J. Acquir Immune Defic. Syndr. 61, 545\u2013551 (2012).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10046_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1124\/jpet.114.217869","volume":"351","author":"PR Purnell","year":"2014","unstructured":"Purnell, P. R. & Fox, H. S. Efavirenz induces neuronal autophagy and mitochondrial alterations. J. Pharm. Exp. Ther. 351, 250\u2013258 (2014).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10046_CR21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jhep.2013.06.005","volume":"59","author":"N Apostolova","year":"2013","unstructured":"Apostolova, N. et al. ER stress in human hepatic cells treated with Efavirenz: mitochondria again. J. Hepatol. 59, 780\u2013789 (2013).","journal-title":"J. Hepatol."},{"key":"10046_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3851\/IMP1418","volume":"14","author":"A Calmy","year":"2009","unstructured":"Calmy, A., Hirschel, B., Cooper, D. A. & Carr, A. A new era of antiretroviral drug toxicity. Antivir. Ther. 14, 165\u2013179 (2009).","journal-title":"Antivir. Ther."},{"key":"10046_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.antiviral.2011.04.018","volume":"91","author":"J Diaz-Delfin","year":"2011","unstructured":"Diaz-Delfin, J. et al. Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines. Antivir. Res 91, 112\u2013119 (2011).","journal-title":"Antivir. Res"},{"key":"10046_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2014.07.008","volume":"19","author":"X Wu","year":"2014","unstructured":"Wu, X., Li, Y., Peng, K. & Zhou, H. HIV protease inhibitors in gut barrier dysfunction and liver injury. Curr. Opin. Pharm. 19, 61\u201366 (2014).","journal-title":"Curr. Opin. Pharm."},{"key":"10046_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0666-1","volume":"16","author":"NS Bhatia","year":"2016","unstructured":"Bhatia, N. S. & Chow, F. C. Neurologic complications in treated HIV-1 infection. Curr. Neurol. Neurosci. Rep. 16, 62 (2016).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10046_CR26","doi-asserted-by":"crossref","unstructured":"Nasi, M. et al. Aging and inflammation in patients with HIV infection. Clin. Exp. Immunol. 187, 44\u201352 (2016).","DOI":"10.1111\/cei.12814"},{"key":"10046_CR27","doi-asserted-by":"crossref","unstructured":"Quiros-Roldan, E., et al. Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012. AIDS Care 28, 1551\u20131558 (2016).","DOI":"10.1080\/09540121.2016.1198750"},{"key":"10046_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/WNL.0b013e31820a0cfc","volume":"76","author":"B Ovbiagele","year":"2011","unstructured":"Ovbiagele, B. & Nath, A. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 76, 444\u2013450 (2011).","journal-title":"Neurology"},{"key":"10046_CR29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1586\/erc.09.72","volume":"7","author":"MR Dobbs","year":"2009","unstructured":"Dobbs, M. R. & Berger, J. R. Stroke in HIV infection and AIDS. Expert Rev. Cardiovasc Ther. 7, 1263\u20131271 (2009).","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10046_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0034-1372341","volume":"34","author":"FC Chow","year":"2014","unstructured":"Chow, F. C. HIV infection, vascular disease, and stroke. Semin Neurol. 34, 35\u201346 (2014).","journal-title":"Semin Neurol."},{"key":"10046_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra041811","volume":"352","author":"S Grinspoon","year":"2005","unstructured":"Grinspoon, S. & Carr, A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N. Engl. J. Med 352, 48\u201362 (2005).","journal-title":"N. Engl. J. Med"},{"key":"10046_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/cid\/civ325","volume":"61","author":"DB Hanna","year":"2015","unstructured":"Hanna, D. B. et al. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin. Infect. Dis. 61, 640\u2013650 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"10046_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s13365-012-0092-3","volume":"18","author":"B Cruse","year":"2012","unstructured":"Cruse, B., Cysique, L. A., Markus, R. & Brew, B. J. Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy. J. Neurovirol 18, 264\u2013276 (2012).","journal-title":"J. Neurovirol"},{"key":"10046_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/infdis\/jix343","volume":"216","author":"B Smith","year":"2017","unstructured":"Smith, B. Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke. J. Infect. Dis. 216, 509\u2013510 (2017).","journal-title":"J. Infect. Dis."},{"key":"10046_CR35","doi-asserted-by":"crossref","unstructured":"Oliveira, R. V. C. et al. Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach. AIDS Care 30, 551\u2013559 (2017).","DOI":"10.1080\/09540121.2017.1391984"},{"key":"10046_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-016-0105-z","volume":"13","author":"G d\u2019Ettorre","year":"2016","unstructured":"d\u2019Ettorre, G. et al. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther. 13, 21 (2016).","journal-title":"AIDS Res Ther."},{"key":"10046_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11906-016-0656-3","volume":"18","author":"R Martin-Iguacel","year":"2016","unstructured":"Martin-Iguacel, R., Negredo, E., Peck, R. & Friis-Moller, N. Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV. Curr. Hypertens. Rep. 18, 46 (2016).","journal-title":"Curr. Hypertens. Rep."},{"key":"10046_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijcard.2015.07.052","volume":"199","author":"C Nduka","year":"2015","unstructured":"Nduka, C., Sarki, A., Uthman, O. & Stranges, S. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis. Int J. Cardiol. 199, 307\u2013318 (2015).","journal-title":"Int J. Cardiol."},{"key":"10046_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.carpath.2015.07.001","volume":"24","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. Cardiovasc Pathol. 24, 279\u2013282 (2015).","journal-title":"Cardiovasc Pathol."},{"key":"10046_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0741-5214(03)00770-5","volume":"38","author":"R Paladugu","year":"2003","unstructured":"Paladugu, R. et al. Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries. J. Vasc. Surg. 38, 549\u2013555 (2003). discussion 555-546.","journal-title":"J. Vasc. Surg."},{"key":"10046_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13365-014-0307-x","volume":"21","author":"BF Guedes","year":"2015","unstructured":"Guedes, B. F. et al. Human immunodeficiency virus-associated vasculopathy with CNS compartmentalization of HIV-1. J. Neurovirol 21, 101\u2013104 (2015).","journal-title":"J. Neurovirol"},{"key":"10046_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(89)91316-0","volume":"1","author":"PL Lantos","year":"1989","unstructured":"Lantos, P. L., McLaughlin, J. E., Schoitz, C. L., Berry, C. L. & Tighe, J. R. Neuropathology of the brain in HIV infection. Lancet 1, 309\u2013311 (1989).","journal-title":"Lancet"},{"key":"10046_CR43","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1212\/NXI.0000000000000254","volume":"3","author":"LA Benjamin","year":"2016","unstructured":"Benjamin, L. A. et al. Arterial ischemic stroke in HIV: Defining and classifying etiology for research studies. Neurol. Neuroimmunol. Neuroinflamm 3, e254 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10046_CR44","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/cid\/cix1075","volume":"66","author":"A Moulignier","year":"2018","unstructured":"Moulignier, A. et al. Silent cerebral small-vessel disease is twice as prevalent in middle-aged individuals with well-controlled, combination antiretroviral therapy-treated human immunodeficiency virus (HIV) than in hiv-uninfected individuals. Clin. Infect. Dis. 66, 1762\u20131769 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"10046_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/QAI.0000000000001358","volume":"75","author":"G Lui","year":"2017","unstructured":"Lui, G. et al. Brief report: progression of atherosclerosis in HIV-infected individuals-prospective data from an Asian Cohort. J. Acquir Immune Defic. Syndr. 75, 198\u2013202 (2017).","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10046_CR46","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","volume":"69","author":"A Kearns","year":"2017","unstructured":"Kearns, A., Gordon, J., Burdo, T. H. & Qin, X. HIV-1-associated atherosclerosis: unraveling the missing link. J. Am. Coll. Cardiol. 69, 3084\u20133098 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10046_CR47","doi-asserted-by":"publisher","first-page":"ofy117","DOI":"10.1093\/ofid\/ofy117","volume":"5","author":"TE Peterson","year":"2018","unstructured":"Peterson, T. E. et al. Inflammation associates with impaired small arterial elasticity early in HIV disease. Open Forum Infect. Dis. 5, ofy117 (2018).","journal-title":"Open Forum Infect. Dis."},{"key":"10046_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jama.2012.6698","volume":"308","author":"S Subramanian","year":"2012","unstructured":"Subramanian, S. et al. Arterial inflammation in patients with HIV. JAMA 308, 379\u2013386 (2012).","journal-title":"JAMA"},{"key":"10046_CR49","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1016\/j.ijcard.2013.06.059","volume":"168","author":"CT Longenecker","year":"2013","unstructured":"Longenecker, C. T. et al. Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy. Int J. Cardiol. 168, 4039\u20134045 (2013).","journal-title":"Int J. Cardiol."},{"key":"10046_CR50","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2174\/0929867322666150209154036","volume":"22","author":"M Kawabori","year":"2015","unstructured":"Kawabori, M. & Yenari, M. A. Inflammatory responses in brain ischemia. Curr. Med Chem. 22, 1258\u20131277 (2015).","journal-title":"Curr. Med Chem."},{"key":"10046_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/CIRCRESAHA.116.308427","volume":"120","author":"X Hu","year":"2017","unstructured":"Hu, X., De Silva, T. M., Chen, J. & Faraci, F. M. Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ. Res 120, 449\u2013471 (2017).","journal-title":"Circ. Res"},{"key":"10046_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0245-4","volume":"12","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia\/macrophage activation during recovery. J. Neuroinflamm. 12, 26 (2015).","journal-title":"J. Neuroinflamm."},{"key":"10046_CR53","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1161\/01.STR.0000083051.93319.28","volume":"34","author":"T Pfefferkorn","year":"2003","unstructured":"Pfefferkorn, T. & Rosenberg, G. A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34, 2025\u20132030 (2003).","journal-title":"Stroke"},{"key":"10046_CR54","doi-asserted-by":"crossref","unstructured":"Venkat, P. Chopp, M. & Chen, J. Blood-Brain Barrier Disruption, Vascular Impairment, and Ischemia\/Reperfusion Damage in Diabetic Stroke. J Am Heart Assoc 6, e005819 (2017).","DOI":"10.1161\/JAHA.117.005819"},{"key":"10046_CR55","doi-asserted-by":"crossref","unstructured":"Jiang X. et al. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog. Neurobiol. 144\u2013171 (2017).","DOI":"10.1016\/j.pneurobio.2017.10.001"},{"key":"10046_CR56","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","volume":"13","author":"J Anrather","year":"2016","unstructured":"Anrather, J. & Iadecola, C. Inflammation and stroke: an overview. Neurotherapeutics 13, 661\u2013670 (2016).","journal-title":"Neurotherapeutics"},{"key":"10046_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin, R., Yang, G. & Li, G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779\u2013789 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"10046_CR58","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.clinbiochem.2008.08.080","volume":"41","author":"V Basic Kes","year":"2008","unstructured":"Basic Kes, V., Simundic, A. M., Nikolac, N., Topic, E. & Demarin, V. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin. Biochem 41, 1330\u20131334 (2008).","journal-title":"Clin. Biochem"},{"key":"10046_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coph.2015.09.009","volume":"26","author":"D Gill","year":"2016","unstructured":"Gill, D. & Veltkamp, R. Dynamics of T cell responses after stroke. Curr. Opin. Pharm. 26, 26\u201332 (2016).","journal-title":"Curr. Opin. Pharm."},{"key":"10046_CR60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2174\/156802609789869619","volume":"9","author":"A Tuttolomondo","year":"2009","unstructured":"Tuttolomondo, A. et al. Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr. Top. Med Chem. 9, 1240\u20131260 (2009).","journal-title":"Curr. Top. Med Chem."},{"key":"10046_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1749-6632.2010.05761.x","volume":"1207","author":"GJ del Zoppo","year":"2010","unstructured":"del Zoppo, G. J. Acute anti-inflammatory approaches to ischemic stroke. Ann. N. Y Acad. Sci. 1207, 143\u2013148 (2010).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10046_CR62","doi-asserted-by":"crossref","unstructured":"Tsou, Y. H., Zhang, X. Q., Zhu, H., Syed, S. & Xu, X. Drug delivery to the brain across the blood-brain barrier using nanomaterials. Small 13, (2017).","DOI":"10.1002\/smll.201701921"},{"key":"10046_CR63","doi-asserted-by":"crossref","unstructured":"Wijaya, J., Fukuda, Y. & Schuetz J. D. Obstacles to brain tumor therapy: key ABC transporters. Int. J. Mol. Sci. 18, 2544 (2017).","DOI":"10.3390\/ijms18122544"},{"key":"10046_CR64","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.2174\/1381612822666160726113001","volume":"22","author":"L Bertrand","year":"2016","unstructured":"Bertrand, L., Nair, M. & Toborek, M. Solving the blood-brain barrier challenge for the effective treatment of hiv replication in the central nervous system. Curr. Pharm. Des. 22, 5477\u20135486 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"10046_CR65","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19745","volume":"17","author":"C Beguelin","year":"2014","unstructured":"Beguelin, C. et al. Viral escape in the CNS with multidrug-resistant HIV-1. J. Int AIDS Soc. 17, 19745 (2014).","journal-title":"J. Int AIDS Soc."},{"key":"10046_CR66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre, S. et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol. 65, 65\u201370 (2008).","journal-title":"Arch. Neurol."},{"key":"10046_CR67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13365-015-0404-5","volume":"22","author":"A Carvalhal","year":"2016","unstructured":"Carvalhal, A. et al. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study. J. Neurovirol 22, 349\u2013357 (2016).","journal-title":"J. Neurovirol"},{"key":"10046_CR68","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","volume":"23","author":"CM Marra","year":"2009","unstructured":"Marra, C. M. et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 23, 1359\u20131366 (2009).","journal-title":"AIDS"},{"key":"10046_CR69","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","volume":"25","author":"M Smurzynski","year":"2011","unstructured":"Smurzynski, M. et al. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS 25, 357\u2013365 (2011).","journal-title":"AIDS"},{"key":"10046_CR70","doi-asserted-by":"crossref","unstructured":"Leda A. R., Dygert L., Bertrand L. & Toborek, M. Mouse microsurgery infusion technique for targeted substance delivery into the CNS via the internal carotid artery. J. Vis. Exp. 119,\u00a0e54804 (2017).","DOI":"10.3791\/54804"},{"key":"10046_CR71","doi-asserted-by":"crossref","unstructured":"Bertrand, L., Dygert, L. & Toborek, M. Induction of ischemic stroke and ischemia-reperfusion in mice using the middle artery occlusion technique and visualization of infarct area. J. Vis. Exp.\u00a0\n                           120, e54805\u00a0(2017).","DOI":"10.3791\/54805"},{"key":"10046_CR72","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang, Y. & Rosenberg, G. A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323\u20133328 (2011).","journal-title":"Stroke"},{"key":"10046_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","volume":"71","author":"HN Siti","year":"2015","unstructured":"Siti, H. N., Kamisah, Y. & Kamsiah, J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vasc. Pharm. 71, 40\u201356 (2015).","journal-title":"Vasc. Pharm."},{"key":"10046_CR74","first-page":"307","volume":"5","author":"BM Famakin","year":"2014","unstructured":"Famakin, B. M. The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review. Aging Dis. 5, 307\u2013326 (2014).","journal-title":"Aging Dis."},{"key":"10046_CR75","doi-asserted-by":"publisher","first-page":"33324","DOI":"10.1074\/jbc.M113.483487","volume":"288","author":"M Park","year":"2013","unstructured":"Park, M., Kim, H. J., Lim, B., Wylegala, A. & Toborek, M. Methamphetamine-induced occludin endocytosis is mediated by the Arp2\/3 complex-regulated actin rearrangement. J. Biol. Chem. 288, 33324\u201333334 (2013).","journal-title":"J. Biol. Chem."},{"key":"10046_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-159","volume":"9","author":"K Ji","year":"2012","unstructured":"Ji, K. & Tsirka, S. E. Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J. Neuroinflamm. 9, 159 (2012).","journal-title":"J. Neuroinflamm."},{"key":"10046_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/srep39738","volume":"6","author":"L Bertrand","year":"2016","unstructured":"Bertrand, L., Dygert, L. & Toborek, M. Antiretroviral treatment with efavirenz disrupts the blood-brain barrier integrity and increases stroke severity. Sci. Rep. 6, 39738 (2016).","journal-title":"Sci. Rep."},{"key":"10046_CR78","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4614-8090-7_6","volume":"8","author":"CG Gahmberg","year":"2014","unstructured":"Gahmberg, C. G., Ning, L. & Paetau, S. ICAM-5: a neuronal dendritic adhesion molecule involved in immune and neuronal functions. Adv. Neurobiol. 8, 117\u2013132 (2014).","journal-title":"Adv. Neurobiol."},{"key":"10046_CR79","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1161\/01.STR.0000244808.17972.55","volume":"37","author":"K Nakaji","year":"2006","unstructured":"Nakaji, K. et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke 37, 2816\u20132823 (2006).","journal-title":"Stroke"},{"key":"10046_CR80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0165-0270(02)00114-0","volume":"117","author":"L Zhang","year":"2002","unstructured":"Zhang, L. et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods 117, 207\u2013214 (2002).","journal-title":"J. Neurosci. Methods"},{"key":"10046_CR81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/NEN.0000000000000026","volume":"73","author":"H He","year":"2014","unstructured":"He, H. et al. Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses. J. Neuropathol. Exp. Neurol. 73, 59\u201371 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10046_CR82","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1073\/pnas.0500649102","volume":"102","author":"MJ Potash","year":"2005","unstructured":"Potash, M. J. et al. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc. Natl Acad. Sci. USA 102, 3760\u20133765 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10046_CR83","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1242\/dmm.012617","volume":"6","author":"E Hadas","year":"2013","unstructured":"Hadas, E. et al. Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus. Dis. Model Mech. 6, 1292\u20131298 (2013).","journal-title":"Dis. Model Mech."},{"key":"10046_CR84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbi.2017.04.024","volume":"65","author":"Y Xing","year":"2017","unstructured":"Xing, Y. et al. MMPs\/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav. Immun. 65, 161\u2013172 (2017).","journal-title":"Brain Behav. Immun."},{"key":"10046_CR85","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/infdis\/jix013","volume":"215","author":"E Rahimy","year":"2017","unstructured":"Rahimy, E. et al. Blood-brain barrier disruption is initiated during primary HIV infection and not rapidly altered by antiretroviral therapy. J. Infect. Dis. 215, 1132\u20131140 (2017).","journal-title":"J. Infect. Dis."},{"key":"10046_CR86","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.brainres.2007.09.063","volume":"1184","author":"H Pu","year":"2007","unstructured":"Pu, H. et al. Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood-brain barrier. Brain Res 1184, 333\u2013344 (2007).","journal-title":"Brain Res"},{"key":"10046_CR87","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/STROKEAHA.117.017287","volume":"49","author":"KA Kim","year":"2018","unstructured":"Kim, K. A. et al. Role of autophagy in endothelial damage and blood-brain barrier disruption in ischemic stroke. Stroke 49, 1571\u20131579 (2018).","journal-title":"Stroke"},{"key":"10046_CR88","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fncel.2018.00288","volume":"12","author":"Y Shen","year":"2018","unstructured":"Shen, Y. et al. Inhibition of HIF-1alpha reduced blood brain barrier damage by regulating MMP-2 and VEGF during acute cerebral ischemia. Front Cell Neurosci. 12, 288 (2018).","journal-title":"Front Cell Neurosci."},{"key":"10046_CR89","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1365-2990.2001.00356.x","volume":"27","author":"S Love","year":"2001","unstructured":"Love, S. & Barber, R. Expression of P-selectin and intercellular adhesion molecule-1 in human brain after focal infarction or cardiac arrest. Neuropathol. Appl Neurobiol. 27, 465\u2013473 (2001).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"10046_CR90","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.CIR.94.5.939","volume":"94","author":"PJ Lindsberg","year":"1996","unstructured":"Lindsberg, P. J., Carpen, O., Paetau, A., Karjalainen-Lindsberg, M. L. & Kaste, M. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94, 939\u2013945 (1996).","journal-title":"Circulation"},{"key":"10046_CR91","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fnmol.2017.00431","volume":"10","author":"S Paetau","year":"2017","unstructured":"Paetau, S., Rolova, T., Ning, L. & Gahmberg, C. G. Neuronal ICAM-5 inhibits microglia adhesion and phagocytosis and promotes an anti-inflammatory response in LPS stimulated microglia. Front Mol. Neurosci. 10, 431 (2017).","journal-title":"Front Mol. Neurosci."},{"key":"10046_CR92","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nm.1927","volume":"15","author":"A Liesz","year":"2009","unstructured":"Liesz, A. et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med 15, 192\u2013199 (2009).","journal-title":"Nat. Med"},{"key":"10046_CR93","doi-asserted-by":"publisher","first-page":"17350","DOI":"10.1523\/JNEUROSCI.4901-12.2013","volume":"33","author":"A Liesz","year":"2013","unstructured":"Liesz, A. et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J. Neurosci. 33, 17350\u201317362 (2013).","journal-title":"J. Neurosci."},{"key":"10046_CR94","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12975-016-0465-7","volume":"7","author":"A Liesz","year":"2016","unstructured":"Liesz, A. & Kleinschnitz, C. Regulatory T Cells in Post-stroke Immune Homeostasis. Transl. Stroke Res 7, 313\u2013321 (2016).","journal-title":"Transl. Stroke Res"},{"key":"10046_CR95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jneumeth.2009.12.020","volume":"187","author":"M Kramer","year":"2010","unstructured":"Kramer, M. et al. TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J. Neurosci. Methods 187, 84\u201389 (2010).","journal-title":"J. Neurosci. Methods"},{"key":"10046_CR96","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bbi.2011.01.013","volume":"25","author":"J Dang","year":"2011","unstructured":"Dang, J., Mitkari, B., Kipp, M. & Beyer, C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav. Immun. 25, 715\u2013726 (2011).","journal-title":"Brain Behav. Immun."},{"key":"10046_CR97","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1124\/mol.115.098590","volume":"88","author":"L Bertrand","year":"2015","unstructured":"Bertrand, L. & Toborek, M. Dysregulation of endoplasmic reticulum stress and autophagic responses by the antiretroviral drug efavirenz. Mol. Pharm. 88, 304\u2013315 (2015).","journal-title":"Mol. Pharm."},{"key":"10046_CR98","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1161\/STROKEAHA.107.488486","volume":"38","author":"O Cuomo","year":"2007","unstructured":"Cuomo, O. et al. Antithrombin reduces ischemic volume, ameliorates neurologic deficits, and prolongs animal survival in both transient and permanent focal ischemia. Stroke 38, 3272\u20133279 (2007).","journal-title":"Stroke"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10046-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T23:07:03Z","timestamp":1671232023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10046-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10046"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10046-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2009"}}